Jubilant Pharmova Q4 Results

  • BSE: 530019
  • NSE: JUBLPHARMA
  • ISIN: INE700A01033
  • Sector: Biotechnology & Drugs
BSE
729.7-2.60 (-0.36%)
Volume9.12 K
Updated: Tue 25 Jun, 2024 | 15:29:29
NSE
725.5-7.30 (-1.00%)
Volume86.41 K
Updated: Tue 25 Jun, 2024 | 15:31:45
Today: 724.25
746.95
52-Wk: 319.30
770.65

Q4 Results Highlights

  • Total Income
    ₹1,758.60 Cr.
    (4.80%)
  • Operating Profit
    ₹1.50 Cr.
    (NA%)
  • Profit After Tax
    ₹-58.60 Cr.
    (-40.11%)
  • Operating Margin
    0.09%
    (NA%)
Note: Comparison is on YoY basis

Quarterly - Jubilant Pharmova Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
Total Revenue 1,758.601,552.514.86%1,678.004.80%
Selling/ General/ Admin Expenses Total 555.00567.94-4.56%534.303.87%
Depreciation/ Amortization 101.0094.286.77%271.23-62.76%
Other Operating Expenses Total 404.80360.6218.47%394.712.56%
Total Operating Expense 1,757.101,500.9113.09%1,730.011.57%
Operating Income 1.5051.60-98.78%-52.010.00%
Net Income Before Taxes -53.708.730.00%-86.41-37.85%
Net Income -58.60-15.670.00%-97.84-40.11%
Diluted Normalized EPS 3.22-0.98-23.26%-6.120.00%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanGet App